BIOMAT Database Logo BIOMAT Database Logo

Amegakaryocytic thrombocytopenic purpura treated with antithymocyte globulin. 1985

A Khelif, and M Ffrench, and G Follea, and B Coiffier, and M Dechavanne, and J J Viala

UI MeSH Term Description Entries
D008297 Male Males
D008533 Megakaryocytes Very large BONE MARROW CELLS which release mature BLOOD PLATELETS. Megakaryocyte
D011696 Purpura, Thrombocytopenic Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms. Purpura, Thrombopenic,Purpuras, Thrombocytopenic,Purpuras, Thrombopenic,Thrombocytopenic Purpura,Thrombocytopenic Purpuras,Thrombopenic Purpura,Thrombopenic Purpuras
D001855 Bone Marrow Diseases Diseases involving the BONE MARROW. Bone Marrow Disease,Disease, Bone Marrow,Diseases, Bone Marrow,Marrow Disease, Bone,Marrow Diseases, Bone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000961 Antilymphocyte Serum Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION. ATGAM,Antilymphoblast Globulins,Antilymphocyte Antibodies,Antilymphocyte Globulin,Lymphocytotoxic Antibodies,Anti-Thymocyte Globulin,Antilymphocyte Immunoglobulin,Antithymocyte Globulin,Antithymoglobulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine),Pressimmune,Anti Thymocyte Globulin,Anti-Thymocyte Globulins,Antibodies, Antilymphocyte,Antibodies, Lymphocytotoxic,Antibody, Antilymphocyte,Antibody, Lymphocytotoxic,Antilymphoblast Globulin,Antilymphocyte Antibody,Antilymphocyte Globulins,Antilymphocyte Immunoglobulins,Antilymphocyte Serums,Antithymocyte Globulins,Antithymoglobulins,Globulin, Anti-Thymocyte,Globulin, Antilymphoblast,Globulin, Antilymphocyte,Globulin, Antithymocyte,Globulins, Anti-Thymocyte,Globulins, Antilymphoblast,Globulins, Antilymphocyte,Globulins, Antithymocyte,Immunoglobulin, Antilymphocyte,Immunoglobulins, Antilymphocyte,Lymphocyte Immune Globulin, Anti Thymocyte Globulin,Lymphocytotoxic Antibody,Serum, Antilymphocyte,Serums, Antilymphocyte
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

A Khelif, and M Ffrench, and G Follea, and B Coiffier, and M Dechavanne, and J J Viala
Successful trial of antithymocyte globulin therapy in amegakaryocytic thrombocytopenic purpura.
June 1988, The Medical journal of Australia,
A Khelif, and M Ffrench, and G Follea, and B Coiffier, and M Dechavanne, and J J Viala
[Acquired amegakaryocytic thrombocytopenic purpura treated with intravenous immunoglobulins].
May 2000, Annales de medecine interne,
A Khelif, and M Ffrench, and G Follea, and B Coiffier, and M Dechavanne, and J J Viala
Successful treatment of acquired amegakaryocytic thrombocytopenic purpura refractory to corticosteroids and intravenous immunoglobulin with antithymocyte globulin and cyclosporin.
September 2008, International journal of hematology,
A Khelif, and M Ffrench, and G Follea, and B Coiffier, and M Dechavanne, and J J Viala
Amegakaryocytic thrombocytopenic purpura.
January 1992, Journal of postgraduate medicine,
A Khelif, and M Ffrench, and G Follea, and B Coiffier, and M Dechavanne, and J J Viala
Acquired amegakaryocytic thrombocytopenic purpura successfully treated with steroid therapy.
October 2005, European journal of internal medicine,
A Khelif, and M Ffrench, and G Follea, and B Coiffier, and M Dechavanne, and J J Viala
Congenital amegakaryocytic thrombocytopenic purpura.
March 1966, Clinical pediatrics,
A Khelif, and M Ffrench, and G Follea, and B Coiffier, and M Dechavanne, and J J Viala
Acquired amegakaryocytic thrombocytopenic purpura.
February 2006, American journal of hematology,
A Khelif, and M Ffrench, and G Follea, and B Coiffier, and M Dechavanne, and J J Viala
[A case of successfully treated cyclic amegakaryocytic thrombocytopenic purpura].
May 1990, Orvosi hetilap,
A Khelif, and M Ffrench, and G Follea, and B Coiffier, and M Dechavanne, and J J Viala
Acquired amegakaryocytic thrombocytopenic purpura successfully treated with limited cyclosporin A therapy.
September 2002, European journal of haematology,
A Khelif, and M Ffrench, and G Follea, and B Coiffier, and M Dechavanne, and J J Viala
Congenital amegakaryocytic thrombocytopenic purpura (CAMT).
April 2014, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
Copied contents to your clipboard!